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rectal cancer with extraregional lymph node metastasis, such as para-aortic lymph node
metastasis, has not been established. The purpose of this study was to evaluate the signifi-
cance of extended lymphadenectomy for colorectal cancer with synchronous isolated extrare-
gional lymph node metastasis.
Methods: Between July 2004 and December 2013, 16 patients with synchronous extraregional
lymph node metastasis without other organ metastases underwent curative resection and
extended lymphadenectomy (R0 group). The clinical characteristics and survival outcomes
of the R0 group were compared with those of 12 patients with extraregional lymph node
metastasis who underwent palliative surgery (control group).
Results: In the R0 group, the 5-year cancer-specific survival (CSS) rate was 70.3% and the 5-
year relapse-free survival (RFS) rate was 60.5%. The 5-year CSS differed significantly between
the R0 and control groups (70.3% vs. 12.5%; pZ 0.0003). Univariate analyses revealed that the
total numbers of metastatic lymph nodes and metastatic regional lymph nodes present were
significantly associated with RFS (p Z 0.019 for both).eclare that they have no conflicts of interest.
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reserved.1. Introduction
Approximately 20% of patients with colorectal cancer are
diagnosed with Stage IV cancer.1 With recent advances in
systemic chemotherapy and improvement in the survival of
patients with stage IV colorectal cancer,2,3 more aggressive
hepatic or pulmonary resection has become a standard
strategy for liver or lung metastasis when R0 resection can
be achieved.4e7 However, the clinical significance of
extended lymphadenectomy for synchronous extraregional
lymph node metastasis, such as para-aortic lymph node
(PALN) metastasis in colorectal cancer, remains highly
controversial. Generally, extraregional lymph node metas-
tasis is considered a systemic disease that is not amenable
to surgical cure. There are very few studies on the benefit
of extended lymphadenectomy for synchronous isolated
extraregional lymph node metastasis in colorectal cancer,
and most of these studies were conducted before the
modern concept of the multimodal approach or they were
case reports.8e10 The purpose of the current study was to
evaluate the clinical significance of extended lymphade-
nectomy for colorectal cancer with synchronous isolated
extraregional lymph node metastasis.
2. Methods
Between July 2004 and December 2013, 4166 patients with
primary colorectal cancer underwent surgery including
noncurative surgery at the Cancer Institute Hospital of the
Japanese Foundation for Cancer Research. Among 668 pa-
tients with Stage IV colorectal cancer who underwent sur-
gery, 36 had isolated synchronous extraregional lymph node
metastasis without other organ metastases such as to the
liver, lungs or peritoneum (Figures 1 and 2). Extraregional
lymph node metastasis was defined as metastasis to lymph
nodes other than the regional mesenteric or mesorectal
lymph nodes. In accordance with the Japanese guidelines,
we considered the lateral pelvic lymph nodes involved in
lower rectal cancer as being regional lymph nodes.11e13
Furthermore, inguinal lymph node metastasis in lower
rectal cancer involving the anal canal was excluded from
the definition of extraregional lymph node metastasis in the
current study.14 Among the 36 patients evaluated in our
study, eight with PALN metastasis located above the renal
vein were excluded because they were not candidates for
curative surgery. Finally, 28 patients with isolated syn-
chronous extraregional lymph node metastasis situated
below the renal vein were included in the current study.
The indications of extended lymphadenectomy for syn-
chronous isolated extraregional lymph node metastasis
were discussed and determined at our multidisciplinarygura A, et al., The significance o
e metastasis, Asian Journal of Suteam meetings. Sixteen patients underwent curative
resection with extended lymphadenectomy (R0 group), and
12 patients underwent noncurative palliative surgery
including stoma construction or exploratory laparotomy
(control group). The clinical characteristics and survival
outcomes were compared between these two groups. All of
the patients in the current study provided informed
consent.
Initial staging included complete physical examination,
chest radiography, chest/abdominal/pelvic computed to-
mography (CT), and colonoscopy. Positron emission to-
mography (PET) was performed in 14 patients (50%); all
patients had radiologic evidence of extraregional lymph
node metastasis with hot uptake detected in PET scans.
Extraregional lymph node metastasis was histologically
confirmed in 15 patients in the R0 group. One patient with
ypT0N0M0 cecal cancer and inguinal lymph node metastasis
who underwent preoperative chemotherapy (6 courses of 5-
fluorouracil, leucovorin, and oxaliplatin (FOLFOX) plus
bevacizumab) was included in the R0 group; this was
because the inguinal lymph node showed clear strong up-
take on PETeCT scans prior to preoperative chemotherapy
(Figure 3). Extraregional lymph node metastasis in the
control group was histologically confirmed in only two pa-
tients; however, the growth and progression of extrare-
gional lymph node metastasis during the clinical course
were confirmed in all patients.
In colon cancer, complete mesocolic excision and D3
lymph node dissection with main feeding artery ligation at
the level of origin was performed. In rectal cancer, total
mesorectal excision with high ligation of the inferior
mesenteric artery was undertaken. With regard to the
extended lymphadenectomy of extraregional lymph node
metastasis, we generally targeted and widely dissected the
region in which the metastasis was observed on radiological
examinations. Follow up of all patients usually consisted of
the following: physical examination (including digital ex-
amination) and blood tests (including measurement of
carcinoembryonic antigen levels) every 3 months; chest/
abdominal/pelvic CT or PETeCT every 6 months; and sur-
veillance colonoscopy 1 year after surgery and every 2 years
thereafter.
Quantitative data are expressed as the median (range).
Survival analysis was performed using the KaplaneMeier
method with the log-rank test using JMP software V11.0
(SAS Institute, Cary, NC, USA) for Windows. Patients who
died from other causes, and those who were living at the
most recent follow up, were censored in the analysis of
cancer-specific survival (CSS). Relapse-free survival (RFS)
was defined as the time from surgery to any type of
recurrence. A p value of <0.05 was considered to indicate a
statistically significant difference.f extended lymphadenectomy for colorectal cancer with isolated
rgery (2015), http://dx.doi.org/10.1016/j.asjsur.2015.10.003
Figure 1 Preoperative radiologic studies from a 56-year-old woman with rectal cancer and para-aortic lymph node (PALN)
metastasis. (A) Computed tomography of the primary lesion (arrowheads) and (B) the PALN (arrow). (C) Positron emission to-
mography-CT with clear uptake by the PALN (arrow).
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The patient and tumor characteristics are summarized in
Table 1. Clinicopathological variables were comparable
between the R0 and control groups with the exception ofFigure 2 Preoperative radiologic studies from a 71-year-old wo
(PALN) metastasis are shown. (A) Computed tomography (CT) of t
Coronal section of the primary lesion (arrowheads) and the PALN (
Please cite this article in press as: Ogura A, et al., The significance o
synchronous extraregional lymph node metastasis, Asian Journal of Suthe location of the tumor (p Z 0.036) and the estimated
blood loss (70 mL vs. 10 mL; p Z 0.013). Surgical time
tended to be longer in the R0 group as compared with the
control group, but the difference was not statistically sig-
nificant (pZ 0.07). The median number of total metastaticman with ascending colon cancer and para-aortic lymph node
he primary lesion (arrowheads) and (B) the PALN (arrow). (C)
arrow).
f extended lymphadenectomy for colorectal cancer with isolated
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Figure 3 Computed tomography (CT) and positron emission tomography-CT scans before (A, B) and after (C, D) the adminis-
tration of neoadjuvant chemotherapy (NAC) in a 59-year-old man with cecal cancer and inguinal lymph node metastasis (arrow).
NAC Z neoadjuvant chemotherapy.
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5.5 (range 3e12) or 1 (range 0e4), respectively. The loca-
tion of extraregional lymph node metastasis in the R0 group
was the PALN in 10 patients, the common iliac nodes in 4
patients (2 with sigmoid colon cancer and 2 with rec-
tosigmoid colon cancer), the external iliac node in 1 patient
with cecal cancer, and the inguinal lymph node in 1 patient
with cecal cancer. The location of extraregional lymph
node metastasis in the control group was the PALN in all
patients. There was no postoperative mortality in either
group. The rate of postoperative complications was not
significantly different between the groups (18.8% vs. 16.7%;
p Z 0.886).
The survival analyses are summarized in Figure 4. The
median follow-up period was 4.9 years (range 0.2e8.6
years). The 5-year CSS rate was significantly different be-
tween the R0 group and the control group (70.3% vs. 12.5%;
pZ 0.0003). The 5-year RFS rate in the R0 group was 60.5%.
To understand which variables had an effect on post-
operative survival, univariate analysis was performed
(Table 2). In the univariate analysis, the number of total
metastatic lymph nodes and the metastatic regional lymph
nodes were significantly associated with RFS (pZ 0.019 for
both).
The details of recurrence in the R0 group are summa-
rized in Table 3. There were seven recurrences in the R0
group. The site of recurrence was the PALN in two patients,
the PALN and the lateral pelvic lymph node in one patient,
the PALN and the liver in one patient, the lateral lymph
node in one patient, the liver in one patient, and the
peritoneum in one patient. Three patients who underwentPlease cite this article in press as: Ogura A, et al., The significance o
synchronous extraregional lymph node metastasis, Asian Journal of Suresection for recurrence were disease free at the last
follow up.4. Discussion
In contrast to liver or lung metastases, there is no
consensus on the treatment strategy for isolated extrare-
gional lymph node metastasis in colorectal cancer. There
have been very few studies on this topic, because isolated
extraregional lymph node metastasis is relatively rare. In
the current study, only 0.67% (28/4166) of the patients with
primary colorectal cancer who underwent surgery had iso-
lated extraregional lymph node metastasis.
Min et al15 reviewed the clinical outcomes of 151 pa-
tients with rectal cancer located 12 cm above the anal
verge, who had received total mesorectal excision plus
extended lymph node dissection between 1996 and 2006.
The 5-year CSS rate was 22.7% for 43 patients with PALN
metastasis and 15.4% for 21 patients with PALN and lateral
pelvic lymph node metastasis. The authors concluded that
extended lymph node dissection might have a curative role
in rectal cancer. Choi et al16 retrospectively reviewed 77
patients with isolated PALN metastasis from colorectal
cancer below the renal vein, between 1993 and 2006.
Twenty-four patients underwent PALN dissection (PALNDþ);
the control group in their study was composed of 53 pa-
tients with isolated PALN metastasis that was not surgically
removed (PALND). The authors reported that the overall
5-year survival rate was 53.4% in the PALNDþ group, but
only 12% for the PALND group (p Z 0.045). However, thef extended lymphadenectomy for colorectal cancer with isolated
rgery (2015), http://dx.doi.org/10.1016/j.asjsur.2015.10.003
Table 1 Patient and tumor characteristics.
Variables R0 group (n Z 16) Control group (n Z 12) p
Sex, n (%) 0.150
Male 5 (31.6) 7 (58.3)
Female 11 (68.4) 5 (41.7)
Age, y (range) 58.5 (39e82) 66 (45e84) 0.119
CEA, ng/mL (range) 8.3 (2.6e154.2) 66.1 (1.6e394.2) 0.889
CA19-9, ng/mL (range) 23.2 (6.4e313.3) 12.0 (2.0e1031.0) 0.486
Location, n (%) 0.0353
Cecum/ascending 3 (18.8) 2 (16.7)
Transverse/descending 0 2 (16.7)
Sigmoid/rectosigmoid 11 (68.8) 3 (25.0)
Rectum 2 (12.4) 5 (41.6)
Histological type, n (%) 0.569
Well/moderate 11 (68.8) 7 (58.3)
Mucinous/poor 5 (31.2) 5 (41.7)
Surgical procedure, n (%) 0.0720
Ileocecal resection/right hemicolectomy 3 (18.8) 2 (16.7)
Transverse colectomy/left hemicolectomy 0 2 (16.7)
Sigmoidectomy/anterior resection 9 (56.2) 2 (16.7)
Low anterior resection 3 (18.8) 2 (16.7)
Abdominoperineal resection 1 (6.2) 1 (8.3)
Stoma construction 0 2 (16.7)
Biopsy of PALN 0 1 (8.3)
Number of LNs (range)
Harvested LNs 20 (13e38) d
Total metastatic LNs 5.5 (3e12) d
Metastatic regional LNs 4 (0e25) d
Metastatic extraregional LNs 1 (0e4) d
Neoadjuvant chemotherapy, n (%) 4 (25) 3 (25) 1
Postoperative chemotherapy, n (%) 15 (93.8) 9 (75) 0.480
Blood loss, mL (range) 70 (5e2020) 10 (0e360) 0.0134
Surgical time, min (range) 240.5 (132e404) 196 (80e282) 0.0702
Morbidity, n (%) 3 (18.8) 2 (16.7) 0.886
Ileus 1 1
Bleeding 1 0
Pelvic dead space infection 1 0
Leakage 0 1
CEA Z carcinoembryonic antigen; LN Z lymph node; PALN Z para-aortic lymph node; POD Z postoperative day.
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nous PALN metastasis (PALN recurrence), in which the
clinical characteristics might be different from those of
synchronous PALN metastasis. The current study focused on
isolated synchronous extraregional lymph node metastasis
in colorectal cancer.
In our study, we showed that the 5-year CSS rate in pa-
tients with isolated extraregional lymph node metastasis in
the R0 group was 70.3%, which was better than those re-
ported in the studies by Min et al15 (22.7%) or Choi et al16
(56.6%). One possible explanation for this superior survival
outcome might have been our careful case selection. We
consider that extended lymphadenectomy for patients with
bead-like extraregional lymph node metastasis, which were
uncountable, had very limited value in improving prognosis.
In the current study, all the extraregional lymph nodes of
the 16 patients who underwent R0 resection were count-
able, were located below the renal vein, and were limited
to that region. In contrast, most patients who underwentPlease cite this article in press as: Ogura A, et al., The significance o
synchronous extraregional lymph node metastasis, Asian Journal of Supalliative surgery had multiple or bead-like extraregional
lymph node metastasis. Therefore, it is natural that the
survival of the 12 patients who underwent palliative surgery
was significantly poorer than that of the patients who un-
derwent R0 resection, because of different backgrounds
and severity. However, we believe that R0 resection is a
prerequisite for the cure of colorectal cancer, and our re-
sults suggest that extended lymphadenectomy for isolated
synchronous extraregional lymph node metastasis might be
effective in improving the prognosis in carefully selected
patients in the modern era of multidisciplinary treatment.
What is a good indication for extended lymphadenec-
tomy in colorectal cancer? Using univariate analysis Choi
et al16 found that the presence of two or fewer PALN me-
tastases was associated with a good prognosis, and they
suggested that the presence of two or fewer PALN metas-
tases is a good indication for PALN dissection. In the current
study, the number of metastatic extraregional lymph nodes
(0e1 or 2) was not significantly associated with RFS,f extended lymphadenectomy for colorectal cancer with isolated
rgery (2015), http://dx.doi.org/10.1016/j.asjsur.2015.10.003
Figure 4 (A) Cancer-specific survival (CSS) curves for the R0 and control groups. (B) Relapse-free survival (RFS) curve for the R0
group. Median observation period is 4.9 years. CSS Z cancer-specific survival; RFS Z relapse-free survival.
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extraregional lymph node metastases tended to be poorer
than that of patients with 0e1 extraregional lymph node
metastasis (28.6% vs. 77.8%). One possible explanation for
the inability to detect the difference might have simply
been related to the small sample size. A second explanation
is that the patient population in our R0 group was carefully
selected. In fact, there was only one patient with three orTable 2 Univariate analyses for prognostic factors in the R0 gr
Variables n 5-y CSS rate (
Sex
Male 5 66.7
Female 11 70.7
Location
Colon 9 59.3
Rectosigmoid/rectum 7 83.3
Cell differentiation
Well/moderate 11 66.7
Mucinous/poor 5 80.0
Preoperative CEA
10 ng/mL 9 71.1
>10 ng/mL 7 71.4
Neoadjuvant chemotherapy
No 12 68.8
Yes 4 75.0
Postoperative chemotherapy
No OHP or CPT-11 6 55.6
OHP or CPT-11 based 10 77.8
Total metastatic LNs
0e6 9 85.7
7 7 51.4
Metastatic extraregional LNs
0e1 9 76.2
2 7 60.0
Metastatic regional LNs
0e3 9 85.7
4 7 51.4
CEA Z carcinoembryonic antigen; CPT-11 Z irinotecan; CSS Z c
RFS Z relapse-free survival.
Please cite this article in press as: Ogura A, et al., The significance o
synchronous extraregional lymph node metastasis, Asian Journal of Sumore extraregional lymph node metastases. Therefore, we
could not determine whether or not patients with three or
more extraregional lymph node metastasis were good can-
didates for extraregional lymphadenectomy. However,
considering that the 5-year CSS was not significantly
different between patients with 0e1 or two or more
extraregional lymph node metastases, our data suggest that
patients with two or fewer extraregional lymph nodeoup.
%) p 5-y RFS rate (%) p
0.880 0.469
80.0
53.0
0.275 0.791
66.7
53.6
0.880 0.381
50.9
80.0
0.866 0.927
66.7
57.1
0.712 0.528
62.5
50.0
0.245 0.843
66.7
58.3
0.156 0.0190
88.9
21.4
0.617 0.182
77.8
28.6
0.156 0.0190
88.9
21.4
ancer-specific survival; LN Z lymph node; OHP Z oxaliplatin;
f extended lymphadenectomy for colorectal cancer with isolated
rgery (2015), http://dx.doi.org/10.1016/j.asjsur.2015.10.003
Table 3 Recurrence after extended lymphadenectomy for extraregional lymph node metastasis.
Case Primary site Recurrence site Recurrence
time from
surgery (mo)
Strategy Prognosis Survival
from surgery
(mo)
1 Sigmoid Liver 14 Chemotherapy Dead 33
2 Sigmoid Liver
PALN
12 Palliative surgery Dead 15
3 Rectosigmoid Lateral lymph node 80 CRT (S-1 þ 50.4 Gy)
/Lateral lymph node
dissection
Recurrence free 94
4 Rectal PALN Lateral lymph node 10 Chemotherapy Dead 45
5 Sigmoid PALN 10 Chemotherapy Dead 43
6 Rectal Peritoneal dissemination 13 Tumor resection Recurrence free 80
7 Rectosigmoid PALN 32 Para-aortic lymphadenectomy Recurrence free 66
PALN Z para-aortic lymph node; CRT Z chemoradiotherapy.
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phadenectomy. In addition, we demonstrated using uni-
variate analysis that the presence of seven or more total
metastatic lymph nodes and four or more metastatic
regional lymph nodes was significantly associated with poor
RFS, although those factors were not significantly associ-
ated with poor CSS.
In seven patients (43.8%), recurrence occurred after
extraregional lymphadenectomy. The most frequent
pattern of the recurrences was extraregional lymph node
recurrence. Interestingly, one patient who underwent re-
resection of recurrence was relapse free at 5 years after re-
resection. Re-resection of recurrence might have a role to
play, even in patients with synchronous extraregional
lymph node metastasis, if the recurrences are limited and
controlled with chemotherapy.
The current study had limitations, including a small
sample size and selection bias. Two different groups were
compared, and it was difficult to directly demonstrate
whether or not extended lymphadenectomy itself
contributed to the improved prognosis. Patients who un-
derwent systemic chemotherapy without surgery were
excluded from the control group, and the perioperative
strategy was not constant. However, our results clearly
showed that long-term survival could be expected in
selected patients with isolated extraregional lymph node
metastasis in colorectal cancer. Therefore, extraregional
lymphadenectomy should be considered for patients with
limited extraregional lymph node metastasis with a bal-
ance between morbidity risk and potential survival
benefit.
In conclusion, our study suggests that extended lym-
phadenectomy for isolated extraregional lymph node
metastasis in colorectal cancer might be an effective
approach for the improvement of prognosis in patients with
limited extraregional lymph node metastasis.References
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